


Nosopharm obtains US patent for NOSO-502, a first-in-class novel antibiotic

Calixar launches new funding round to establish business strategy

Domain Therapeutics acquires Prestwick Chemical and Neurofit to bolster next stage of growth

PDC*line Pharma announces the administration of a first patient with its therapeutic cancer vaccine candidate (PDC*lung01) targeting non-small cell lung cancer

Advanced BioDesign raises additional €9 million from Xerys Funds

Oncodesign and Servier reach a key first milestone in their strategic partnership

Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking

Yposkesi’s clinical batches of the G1XCGD lentiviral vector used in rare immune system disease study
